Patient-assessed Outcomes in Swedish and Egyptian Men Undergoing Radical Cystectomy and Orthotopic Bladder Substitution--a Prospective Comparative Study
Affiliations
Objectives: To compare two patient populations with assumed cultural differences undergoing radical cystectomy and orthotopic bladder substitution to determine whether these translate into differences in the answers to self-report instruments.
Methods: The questionnaires Functional Assessment of Cancer Therapy-Bladder Cancer (FACT-BL), consisting of a general version (FACT-G) and a bladder cancer specific module, and Hospital Anxiety and Depression Scale (HADS) were used preoperatively and 3 and 12 months postoperatively to assess patient well-being, urologic symptoms, depression, and anxiety in 29 and 32 Swedish and Egyptian male patients, respectively.
Results: Significant differences were found between the two groups. Higher FACT-G scores (ie, better outcomes) were obtained in the Swedish patients, both preoperatively and 3 months postoperatively, but not after 12 months. Differences were also seen in the urogenital assessment provided by the FACT-BL module. HADS revealed more depression among the Egyptian patients throughout the study period. Also, anxiety was more common preoperatively and 3 months postoperatively in the Egyptian patients, but not after 12 months.
Conclusions: Swedish men scored better than Egyptian men on the FACT-BL and HADS, although the latter improved with time after surgery. These results show that patient-assessed outcomes differ in patients from different sociocultural backgrounds. This should be recognized when analyzing results from comparative studies. Also, the use of culture-fair instruments is important when assessing patients with different sociocultural backgrounds.
Guo M, Li Y, Wang W, Kang X, Chen G Front Surg. 2022; 9:893249.
PMID: 35928029 PMC: 9343671. DOI: 10.3389/fsurg.2022.893249.
The Significant Role of Depression in Elderly Patients with Bladder Cancer.
Oserowsky A, Anwar T, Lough C, Golzy M, Murray K Eur Urol Open Sci. 2021; 33:11-18.
PMID: 34723216 PMC: 8546926. DOI: 10.1016/j.euros.2021.08.007.
Walker Z, Xue S, Jones M, Ravindran A JCO Glob Oncol. 2021; 7:1233-1250.
PMID: 34343029 PMC: 8457869. DOI: 10.1200/GO.21.00056.
Rangarajan K, Somani B Arab J Urol. 2019; 17(3):181-194.
PMID: 31489233 PMC: 6711151. DOI: 10.1080/2090598X.2019.1600279.
Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients.
Vartolomei L, Ferro M, Mirone V, Shariat S, Vartolomei M Bladder Cancer. 2018; 4(3):319-326.
PMID: 30112443 PMC: 6087432. DOI: 10.3233/BLC-180181.